Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
Hand-out
Press Releases
Inhibrx Biosciences, Inc.  
November 4, 2024

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with two programs in ongoing clinical trials and a strong emerging

avatar profile Olean Times Herald

Olean Times Herald


Local & Social